FDA announces new treatment option for aggressive breast cancer

Name: FDA announces new treatment option for aggressive breast cancer
Uploaded: 2026-06-25T11:39:51
Duration: PT77.0S
Description: Trodelvy is now approved as a first treatment for triple-negative breast cancer, one of the most difficult forms of breast cancer to treat.

Trodelvy is now approved as a first treatment for triple-negative breast cancer, one of the most difficult forms of breast cancer to treat.